---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-008452"
form_type: "8-K"
ticker: "TENX"
cik: "0000034956"
company_name: "TENAX THERAPEUTICS, INC."
filed_at: "2022-06-16T23:59:59+00:00"
generated_at: "2026-06-25T01:25:05.668025+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Two Armistice Capital directors resign from Tenax board; Armistice waives appointment right

## Summary
- Steven Boyd and Keith Maher resigned from Tenax board effective June 10, 2022; no disagreement cited.
- Boyd and Maher were designees of Armistice Capital Master Fund Ltd., which had right to appoint two directors.
- On June 13, 2022, Armistice irrevocably waived its appointment right under the July 2020 Purchase Agreement.
- The waiver eliminates Armistice's ability to designate future board members.

## SEC filing metadata
- accession: 0001654954-22-008452
- form_type: 8-K
- ticker: TENX
- cik: 0000034956
- company_name: TENAX THERAPEUTICS, INC.
- filed_at: 2022-06-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/0001654954-22-008452-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/tenx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-008452
- JSON: https://secwatch.observer/filing/0001654954-22-008452.json
- Plain text: https://secwatch.observer/filing/0001654954-22-008452.txt

## Key facts
- Executive change
  Keith Maher resigned as Director at TENAX THERAPEUTICS, INC..
  - Action: resigned
  - Role: Director
  source text: On June 10, 2022, Steven Boyd and Keith Maher, MD, both of Armistice Capital, LLC, the investment manager to Armistice Capital Master Fund Ltd. (the “Master Fund”), notified the Board of Directors (the “Board”) of Tenax Therapeutics, Inc. (the “Company”) that they have resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/0001654954-22-008452-index.htm
- Executive change
  Steven Boyd resigned as Director at TENAX THERAPEUTICS, INC..
  - Action: resigned
  - Role: Director
  source text: On June 10, 2022, Steven Boyd and Keith Maher, MD, both of Armistice Capital, LLC, the investment manager to Armistice Capital Master Fund Ltd. (the “Master Fund”), notified the Board of Directors (the “Board”) of Tenax Therapeutics, Inc. (the “Company”) that they have resigned from the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/0001654954-22-008452-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.